SP 9.07 Novel Blood-Based Biomarkers of Frailty and Outcomes Following Emergency Laparotomy
This study is among the first to characterise blood-based frailty metabolites in EmLap patients using LCMS-based metabolomics, and offers a novel, objective approach for frailty assessment and peri-operative risk stratification, with potential implications for targeted optimisation and future therapeutic development.